Browse the latest research summaries in the field of endocrinology for spinal cord injury patients and caregivers.
Showing 41-50 of 211 results
Journal of Clinical Medicine, 2021 • November 28, 2021
This study evaluated various indices of glucose metabolism in individuals with chronic motor complete SCI to determine their agreement with IVGTT-measured insulin sensitivity (Si). The findings indica...
KEY FINDING: QUICKI (Quantitative Insulin-sensitivity Check Index) showed the strongest agreement with insulin sensitivity (Si) as measured by the IVGTT.
Journal of Frailty, Sarcopenia and Falls, 2021 • December 1, 2021
Osteosarcopenia has been proposed as a syndrome in a subset of frail individuals at higher risk of falls, fractures and institutionalization. A new holistic concept called Osteosarcopenia School will ...
KEY FINDING: Osteosarcopenia and osteosarcopenia with a severe sarcopenia component may occur in both osteoporotic and osteopenic individuals, increasing symmetrically fracture risk.
Spinal Cord Series and Cases, 2022 • January 5, 2022
This retrospective study aimed to determine the incidence of hyponatremia and associated factors in patients with traumatic cervical spinal cord injury (SCI). The study found a high incidence of hypon...
KEY FINDING: Hyponatremia developed in 43.9% of traumatic cervical SCI patients.
Obes Facts, 2022 • March 9, 2022
The study aimed to determine the rates, variability, and predictors of guideline-concordant annual screening for obesity among individuals with SCI within the VHA system. The study found that a signif...
KEY FINDING: A large proportion (37.9%) of persons with SCI receiving care in VHA do not receive guideline-concordant annual obesity screening.
Annals of Rehabilitation Medicine, 2022 • February 28, 2022
This study investigated risk factors for Metabolic Syndrome (MetS) in individuals with Spinal Cord Injury (SCI) and assessed the correlation between anthropometric measures and MetS subfactors. The re...
KEY FINDING: Increasing age and lower neurological level of injury were significant risk factors for MetS.
Annals of Rehabilitation Medicine, 2022 • February 1, 2022
This corrigendum addresses a correction to a previously published article concerning factors affecting metabolic syndrome in individuals with chronic spinal cord injury. The correction involves the se...
KEY FINDING: The only finding is the correction of the second author's name from Tayeon Kim to Tayeun Kim.
BMC Musculoskeletal Disorders, 2022 • May 16, 2022
The FIT-SCI trial is designed to evaluate the efficacy of a home-based multimodality intervention combining FES-LC, AE, and androgen therapy for individuals with SCI. The study employs a randomized, p...
KEY FINDING: The study hypothesizes that combining FES-LC plus AE with testosterone treatment will be more effective than FES-LC, AE, and a placebo in improving various health parameters.
Frontiers in Endocrinology, 2022 • June 20, 2022
This study investigates the interaction between melanocortin 1 receptor (Mc1r) and melanocortin receptor-associated proteins (Mraps) in Xenopus tropicalis. The research combines in silico analysis wit...
KEY FINDING: xtMc1r interacts directly with xtMrap1 and xtMrap2 proteins on the plasma membrane, validated through co-immunoprecipitation and fluorescence.
J. Pers. Med., 2022 • June 30, 2022
Cardiometabolic risk and CMS are a significant global public health crisis for the population with SCI. Many people with SCI present with cardiometabolic risk factors, the most serious of which is obe...
KEY FINDING: Obesity after SCI is characterized not just by increased body fat but by the dysregulation of adipose tissue, leading to inflammation, insulin resistance, and other metabolic issues.
Frontiers in Endocrinology, 2022 • July 19, 2022
This cross-sectional study explored the prevalence of indices of sarcopenic obesity in patients with NDS. Our findings revealed statistically significant associations between BMI and SMI in both gende...
KEY FINDING: A statistically significant difference was found in SMI between controls and patients with NDS.